Clinical Trials on Plaque Psoriasis Vulgaris
Total 3760 results
-
University of California, San FranciscoCompletedChronic Stable Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States, Estonia, Japan, Latvia, Canada, Iceland
-
South Valley UniversityCompleted
-
Novartis PharmaceuticalsCompletedChronic Severe Plaque-type PsoriasisBelgium, Italy, Egypt, France, Hungary, Russian Federation, Germany, Israel, Spain, Japan, Estonia, United Kingdom, Poland, Colombia, United States, Latvia, Guatemala, Romania, Switzerland
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
CelltrionRecruitingModerate to Severe Chronic Plaque PsoriasisEstonia
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Kadmon Corporation, LLCCompletedChronic Plaque PsoriasisUnited States
-
Astellas Pharma IncBiogenCompleted
-
Herlev and Gentofte HospitalRecruitingMyocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Heart Failure | Stroke | Psoriasis | Heart Failure, Diastolic | Psoriasis Vulgaris | Cardiovascular Risk Factor | Heart Failure, Systolic | Left Ventricular Dysfunction | Psoriasis Universalis | Psoriasis Face | Psoriasis Diffusa | Psoriasis... and other conditionsDenmark
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
AbbVie (prior sponsor, Abbott)IMS HealthCompletedModerate-to-severe Chronic Plaque Psoriasis
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
LEO PharmaRecruitingPsoriasis VulgarisBelgium, Italy, Spain, Germany, Czechia, Greece, United Kingdom, France, Hungary, Poland, Netherlands
-
Arctic Nutrition ASUniversity of Bergen; Haukeland University HospitalCompletedPsoriasis VulgarisNorway
-
PfizerCompletedPsoriasis | Psoriasis VulgarisUnited States, Canada, Denmark, Poland
-
Josip Juraj Strossmayer University of OsijekRecruitingPsoriasis VulgarisCroatia
-
Aarhus University HospitalActive, not recruitingSkin Diseases | Psoriasis | Skin Diseases, Papulosquamous | Psoriasis Vulgaris | Skin and Connective Tissue DiseasesDenmark
-
LEO PharmaCompleted
-
Istanbul Medeniyet UniversityCompletedMetabolic Syndrome | Psoriasis Vulgaris | Psoriatic ArthritisTurkey
-
AbbViePPDRecruitingPlaque Psoriasis | Crohn Disease | Psoriatic Arthritis | Other Conditions for Which Risankizumab is an FDA-approved TreatmentUnited States
-
The 306 Hospital of People's Liberation ArmyUnknownVulgaris PsoriasisChina
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, France, Estonia, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Novartis PharmaceuticalsCompleted
-
Diamant ThaciWithdrawnModerate to Severe Plaque PsoriasisGermany
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Canada
-
Sienna BiopharmaceuticalsCompletedPruritus | Psoriasis VulgarisUnited States
-
PfizerCompletedRheumatoid Arthritis | Plaque Psoriasis | Psoriatic Arthritis | Axial SpondyloarthritisGermany
-
Coherus Biosciences, Inc.Shire; Daiichi Sankyo Co., Ltd.Completed
-
Janssen Biotech, Inc.CompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisChina, Thailand, Philippines, Turkey, Hungary, Malaysia
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Canada
-
BrosMed Medical Co., LtdCompletedPatients With Atherosclerotic Plaques in the Coronary Arteries That Require ExcisionChina
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany
-
Nick van der BeekAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Active, not recruitingPsoriasis VulgarisNetherlands
-
University of ZurichUnknownPsoriasis Vulgaris | Psoriasis of ScalpSwitzerland
-
Almirall, S.A.Completed
-
AbbVie (prior sponsor, Abbott)Raffeiner GmbHCompletedModerate to Severe Plaque Psoriasis